Related Articles
Detection of RB, p16/CDKN2 and p15(INK4B) gene alterations with immunohistochemical studies in human prostate carcinomas
CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas.
Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.
Decreased expression of p16 gene in gastric cancer
p16 involvement in primary bladder tumors: analysis of deletions and mutations.